|

Mycophenolate Sodium Clinical Trials

2 actively recruiting trials across 1 location

Also known as: ERL 080, ERL 080A, Socium Mycophenolate

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • Fred Hutchinson Cancer Center2

Indications

  • Cancer2
  • Refractory Acute Undifferentiated Leukemia1
  • Refractory Acute Leukemia of Ambiguous Lineage1
  • Adult Diffuse Large Cell Lymphoma1
  • Refractory Marginal Zone Lymphoma1

Seattle, Washington2 trials

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Fred Hutch/University of Washington Cancer Consortium

Phase 1
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Fred Hutch/University of Washington Cancer Consortium

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.